-
1
-
-
0042195833
-
Major risk factors as antecedents of fatal and nonfatal coronary heart disease events
-
P. Greenland, M.D. Knoll, and J. Stamler Major risk factors as antecedents of fatal and nonfatal coronary heart disease events JAMA 290 2003 891 897
-
(2003)
JAMA
, vol.290
, pp. 891-897
-
-
Greenland, P.1
Knoll, M.D.2
Stamler, J.3
-
2
-
-
0042697063
-
Prevalence of conventional risk factors in patients with coronary heart disease
-
U.N. Khot, M.B. Khot, and C.T. Bajzer Prevalence of conventional risk factors in patients with coronary heart disease JAMA 290 2003 898 904
-
(2003)
JAMA
, vol.290
, pp. 898-904
-
-
Khot, U.N.1
Khot, M.B.2
Bajzer, C.T.3
-
3
-
-
0037078969
-
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
-
P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
-
(2002)
N Engl J Med
, vol.347
, pp. 1557-1565
-
-
Ridker, P.M.1
Rifai, N.2
Rose, L.3
Buring, J.E.4
Cook, N.R.5
-
4
-
-
0027406191
-
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial
-
J. Stamler, O. Vaccaro, J.D. Neaton, and D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
-
(1993)
Diabetes Care
, vol.16
, pp. 434-444
-
-
Stamler, J.1
Vaccaro, O.2
Neaton, J.D.3
Wentworth, D.4
-
5
-
-
0026707277
-
Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus
-
C.J. Schwartz, A.J. Valente, E.A. Sprague, J.L. Kelley, A.J. Cayatte, and M.M. Rozek Pathogenesis of the atherosclerotic lesion. Implications for diabetes mellitus Diabetes Care 15 1992 1156 1167
-
(1992)
Diabetes Care
, vol.15
, pp. 1156-1167
-
-
Schwartz, C.J.1
Valente, A.J.2
Sprague, E.A.3
Kelley, J.L.4
Cayatte, A.J.5
Rozek, M.M.6
-
6
-
-
0032560807
-
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
-
S.M. Haffner, S. Lehto, T. Ronnemaa, K. Pyorala, and M. Laakso Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 1998 229 234
-
(1998)
N Engl J Med
, vol.339
, pp. 229-234
-
-
Haffner, S.M.1
Lehto, S.2
Ronnemaa, T.3
Pyorala, K.4
Laakso, M.5
-
7
-
-
0035908632
-
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus
-
A.D. Pradhan, J.E. Manson, N. Rifai, J.E. Buring, and P.M. Ridker C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus JAMA 286 2001 327 334
-
(2001)
JAMA
, vol.286
, pp. 327-334
-
-
Pradhan, A.D.1
Manson, J.E.2
Rifai, N.3
Buring, J.E.4
Ridker, P.M.5
-
8
-
-
0038691972
-
Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study
-
B.B. Duncan, M.I. Schmidt, and J.S. Pankow Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study Diabetes 52 2003 1799 1805
-
(2003)
Diabetes
, vol.52
, pp. 1799-1805
-
-
Duncan, B.B.1
Schmidt, M.I.2
Pankow, J.S.3
-
9
-
-
0037022910
-
Inflammation and atherosclerosis
-
P. Libby, P.M. Ridker, and A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
-
(2002)
Circulation
, vol.105
, pp. 1135-1143
-
-
Libby, P.1
Ridker, P.M.2
Maseri, A.3
-
10
-
-
0142061128
-
Circulating markers of inflammation and atherosclerosis
-
L. Lind Circulating markers of inflammation and atherosclerosis Atherosclerosis 169 2003 203 214
-
(2003)
Atherosclerosis
, vol.169
, pp. 203-214
-
-
Lind, L.1
-
11
-
-
1442275317
-
Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes
-
J.C. Pickup Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes Diabetes Care 27 2004 813 823
-
(2004)
Diabetes Care
, vol.27
, pp. 813-823
-
-
Pickup, J.C.1
-
12
-
-
2142649221
-
Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus
-
J.B. Meigs, F.B. Hu, N. Rifai, and J.E. Manson Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus JAMA 291 2004 1978 1986
-
(2004)
JAMA
, vol.291
, pp. 1978-1986
-
-
Meigs, J.B.1
Hu, F.B.2
Rifai, N.3
Manson, J.E.4
-
13
-
-
0035897688
-
Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease
-
P.M. Ridker, M.J. Stampfer, and N. Rifai Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
-
(2001)
JAMA
, vol.285
, pp. 2481-2485
-
-
Ridker, P.M.1
Stampfer, M.J.2
Rifai, N.3
-
14
-
-
21344460247
-
An immune origin of type 2 diabetes?
-
H. Kolb, and T. Mandrup-Poulsen An immune origin of type 2 diabetes? Diabetologia 48 2005 1038 1050
-
(2005)
Diabetologia
, vol.48
, pp. 1038-1050
-
-
Kolb, H.1
Mandrup-Poulsen, T.2
-
15
-
-
15944419583
-
N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults
-
C. Kistorp, I. Raymond, F. Pedersen, F. Gustafsson, J. Faber, and P. Hildebrandt N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults JAMA 293 2005 1609 1616
-
(2005)
JAMA
, vol.293
, pp. 1609-1616
-
-
Kistorp, C.1
Raymond, I.2
Pedersen, F.3
Gustafsson, F.4
Faber, J.5
Hildebrandt, P.6
-
16
-
-
34548425213
-
N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population
-
M.H. Olsen, T.W. Hansen, and M.K. Christensen N-terminal pro-brain natriuretic peptide, but not high sensitivity C-reactive protein, improves cardiovascular risk prediction in the general population Eur Heart J 28 2007 1374 1381
-
(2007)
Eur Heart J
, vol.28
, pp. 1374-1381
-
-
Olsen, M.H.1
Hansen, T.W.2
Christensen, M.K.3
-
17
-
-
23844491509
-
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: The Framingham Heart Study
-
J. Arnlov, J.C. Evans, and J.B. Meigs Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study Circulation 112 2005 969 975
-
(2005)
Circulation
, vol.112
, pp. 969-975
-
-
Arnlov, J.1
Evans, J.C.2
Meigs, J.B.3
-
18
-
-
33748485114
-
YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis
-
C.N. Rathcke, and H. Vestergaard YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis Inflamm Res 55 2006 221 227
-
(2006)
Inflamm Res
, vol.55
, pp. 221-227
-
-
Rathcke, C.N.1
Vestergaard, H.2
-
19
-
-
0022453659
-
In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells
-
A.J. Millis, M. Hoyle, and L. Kent In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells J Cell Physiol 127 1986 366 372
-
(1986)
J Cell Physiol
, vol.127
, pp. 366-372
-
-
Millis, A.J.1
Hoyle, M.2
Kent, L.3
-
20
-
-
0029039184
-
Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling
-
L.M. Shackelton, D.M. Mann, and A.J. Millis Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling J Biol Chem 270 1995 13076 13083
-
(1995)
J Biol Chem
, vol.270
, pp. 13076-13083
-
-
Shackelton, L.M.1
Mann, D.M.2
Millis, A.J.3
-
21
-
-
0031470037
-
Smooth muscle migration in vascular development and pathogenesis
-
S.M. Schwartz Smooth muscle migration in vascular development and pathogenesis Transpl Immunol 5 1997 255 260
-
(1997)
Transpl Immunol
, vol.5
, pp. 255-260
-
-
Schwartz, S.M.1
-
22
-
-
0037530029
-
Gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells
-
K.C. Nishikawa, and A.J. Millis gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells Exp Cell Res 287 2003 79 87
-
(2003)
Exp Cell Res
, vol.287
, pp. 79-87
-
-
Nishikawa, K.C.1
Millis, A.J.2
-
23
-
-
0032975495
-
Strong induction of members of the chitinase family of proteins in atherosclerosis: Chitotriosidase and human cartilage gp-39 expressed in lesion macrophages
-
R.G. Boot, T.A. van Achterberg, and B.E. van Aken Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages Arterioscler Thromb Vasc Biol 19 1999 687 694
-
(1999)
Arterioscler Thromb Vasc Biol
, vol.19
, pp. 687-694
-
-
Boot, R.G.1
Van Achterberg, T.A.2
Van Aken, B.E.3
-
24
-
-
12744279375
-
In vitro biomarker discovery for atherosclerosis by proteomics
-
E.M. Fach, L.A. Garulacan, and J. Gao In vitro biomarker discovery for atherosclerosis by proteomics Mol Cell Proteomics 3 2004 1200 1210
-
(2004)
Mol Cell Proteomics
, vol.3
, pp. 1200-1210
-
-
Fach, E.M.1
Garulacan, L.A.2
Gao, J.3
-
25
-
-
33645815907
-
YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance
-
C.N. Rathcke, J.S. Johansen, and H. Vestergaard YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance Inflamm Res 55 2006 53 59
-
(2006)
Inflamm Res
, vol.55
, pp. 53-59
-
-
Rathcke, C.N.1
Johansen, J.S.2
Vestergaard, H.3
-
26
-
-
0344974146
-
The Frederiksberg Heart Failure Study: Rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population
-
I. Raymond, F. Pedersen, M. Busch-Sorensen, A. Green, and P.R. Hildebrandt The Frederiksberg Heart Failure Study: rationale, design and methodology, with special emphasis on the sampling procedure for the study population and its comparison to the background population HeartDrug 2002 2002 167 174
-
(2002)
HeartDrug
, vol.2002
, pp. 167-174
-
-
Raymond, I.1
Pedersen, F.2
Busch-Sorensen, M.3
Green, A.4
Hildebrandt, P.R.5
-
27
-
-
3142735789
-
The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: A population-based study of 13,000 men and women with 20 years of follow-up
-
T. Almdal, H. Scharling, J.S. Jensen, and H. Vestergaard The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up Arch Intern Med 164 2004 1422 1426
-
(2004)
Arch Intern Med
, vol.164
, pp. 1422-1426
-
-
Almdal, T.1
Scharling, H.2
Jensen, J.S.3
Vestergaard, H.4
-
28
-
-
37849030677
-
High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality
-
J.S. Johansen, A.N. Pedersen, M. Schroll, T. Jorgensen, B.K. Pedersen, and H. Bruunsgaard High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality Clin Exp Immunol 151 2008 260 266
-
(2008)
Clin Exp Immunol
, vol.151
, pp. 260-266
-
-
Johansen, J.S.1
Pedersen, A.N.2
Schroll, M.3
Jorgensen, T.4
Pedersen, B.K.5
Bruunsgaard, H.6
-
29
-
-
36148981436
-
A chitinase-like protein in the lung and circulation of patients with severe asthma
-
G.L. Chupp, C.G. Lee, and N. Jarjour A chitinase-like protein in the lung and circulation of patients with severe asthma N Engl J Med 357 2007 2016 2027
-
(2007)
N Engl J Med
, vol.357
, pp. 2016-2027
-
-
Chupp, G.L.1
Lee, C.G.2
Jarjour, N.3
-
30
-
-
33646842919
-
Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer
-
J.S. Johansen Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer Dan Med Bull 53 2006 172 209
-
(2006)
Dan Med Bull
, vol.53
, pp. 172-209
-
-
Johansen, J.S.1
-
31
-
-
34547531506
-
Serum YKL-40 levels in patients with coronary artery disease
-
M. Kucur, F.K. Isman, B. Karadag, V.A. Vural, and S. Tavsanoglu Serum YKL-40 levels in patients with coronary artery disease Coron Artery Dis 18 2007 391 396
-
(2007)
Coron Artery Dis
, vol.18
, pp. 391-396
-
-
Kucur, M.1
Isman, F.K.2
Karadag, B.3
Vural, V.A.4
Tavsanoglu, S.5
-
32
-
-
54749135440
-
Serum levels of YKL-40 increases in patients with acute myocardial infarction
-
C. Nojgaard, N.B. Host, and I.J. Christensen Serum levels of YKL-40 increases in patients with acute myocardial infarction Coron Artery Dis 19 2008 257 263
-
(2008)
Coron Artery Dis
, vol.19
, pp. 257-263
-
-
Nojgaard, C.1
Host, N.B.2
Christensen, I.J.3
-
33
-
-
43549117072
-
Use of multiple biomarkers to improve the prediction of death from cardiovascular causes
-
B. Zethelius, L. Berglund, and J. Sundstrom Use of multiple biomarkers to improve the prediction of death from cardiovascular causes N Engl J Med 358 2008 2107 2116
-
(2008)
N Engl J Med
, vol.358
, pp. 2107-2116
-
-
Zethelius, B.1
Berglund, L.2
Sundstrom, J.3
-
34
-
-
57549110416
-
Ethical authorship and publishing
-
A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150
-
(2009)
Int J Cardiol
, vol.131
, pp. 149-150
-
-
Coats, A.J.1
|